| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7754210 | Journal of Inorganic Biochemistry | 2018 | 8 Pages |
Abstract
Ruthenium (II) complexes with the anticancer agent CHS-828 {N-[6-(4-chlorophenoxy)hexyl]-Nâ²-cyano-Nâ³-4-pyridyl guanidine} as a ligand are stable in the dark and accumulate in tumour cells at high concentrations. Irradiation of the cells leads to release of CHS-828 and cell death.58
Related Topics
Physical Sciences and Engineering
Chemistry
Inorganic Chemistry
Authors
Jianhua Wei, Anna K. Renfrew,